Show simple item record

dc.contributor.authorEbert, Natalie
dc.contributor.authorSchaeffner, Elke
dc.contributor.authorSeegmiller, Jesse C.
dc.contributor.authorvan Londen, Marco
dc.contributor.authorBökenkamp, Arend
dc.contributor.authorCavalier, Etienne
dc.contributor.authorDelanaye, Pierre
dc.contributor.authorDerain-Dubourg, Laurence
dc.contributor.authorEriksen, Bjørn Odvar
dc.contributor.authorIndridason, Olafur S.
dc.contributor.authorPalsson, Runolfur
dc.contributor.authorShafi, Tariq
dc.contributor.authorChristensson, Anders
dc.contributor.authorBevc, Sebastjan
dc.contributor.authorCarrara, Fabiola
dc.contributor.authorCourbebaisse, Marie
dc.contributor.authorDalton, R. Neil
dc.contributor.authorvan der Giet, Markus
dc.contributor.authorMelsom, Toralf
dc.contributor.authorMethven, Shona
dc.contributor.authorNordin, Gunnar
dc.contributor.authorPottel, Hans
dc.contributor.authorRule, Andrew D.
dc.contributor.authorTrillini, Matias
dc.contributor.authorWhite, Christine A.
dc.date.accessioned2024-11-04T13:54:43Z
dc.date.available2024-11-04T13:54:43Z
dc.date.issued2024-08-07
dc.description.abstractInternational consensus supports the development of standardized protocols for measured glomerular filtration rate (mGFR) to facilitate the integration of mGFR testing in both clinical and research settings. To this end, the European Kidney Function Consortium convened an international group of experts with relevant experience in mGFR. The working group performed an extensive literature search to inform the development of recommendations for mGFR determination using 1-compartment plasma clearance models and iohexol as the exogenous filtration marker. Iohexol was selected as it is non–radio labeled, inexpensive, and safe, can be assayed at a central laboratory, and the other commonly used non–radio-labeled tracers have been (inulin) or are soon to be (iothalamate) discontinued. A plasma clearance model was selected over urine clearance as it requires no urine collection. A 1 compartment was preferred to 2 compartments as it requires fewer samples. The recommendations are based on published evidence complemented by expert opinion. The consensus paper covers practical advice for patients and health professionals, preparation, administration, and safety aspects of iohexol, laboratory analysis, blood sample collection and sampling times using both multiple and single-sample protocols, description of the mGFR mathematical calculations, as well as implementation strategies. Supplementary materials include patient and provider information sheets, standard operating procedures, a study protocol template, and support for mGFR calculation.en_US
dc.identifier.citationEbert, Schaeffner, Seegmiller, van Londen, Bökenkamp, Cavalier, Delanaye, Derain-Dubourg, Eriksen, Indridason, Palsson, Shafi, Christensson, Bevc, Carrara, Courbebaisse, Dalton, van der Giet, Melsom, Methven, Nordin, Pottel, Rule, Trillini, White. Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium. Kidney International. 2024en_US
dc.identifier.cristinIDFRIDAID 2298846
dc.identifier.doi10.1016/j.kint.2024.06.029
dc.identifier.issn0085-2538
dc.identifier.issn1523-1755
dc.identifier.urihttps://hdl.handle.net/10037/35426
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.journalKidney International
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2024 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)en_US
dc.titleIohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortiumen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)